Exchange: NASDAQ·Updated 03:59 PM EDT

DECADenali Capital Acquisition Corp - Ordinary Shares - Class A

$0.6402
$0.1698
(20.96%)
Today
Mkt Cap$186.47M
Vol7,383.00
News
all
press releases
Scilex Subsidiary Semnur Pharma Eyes $20M Private Placement Deal: More Details Inside
The proceeds of the agreement will be used to advance the second late-stage clinical trial for the development of SP-102, a viscous gel formulation of a widely used corticosteroid for epidural injections, for the treatment of lumbosacral radicular pain.
Stocktwits
Small-Cap Scilex Drew Biggest Jump In Retail Following For July: What Drove It?
Retail investors flocked to Scilex, drawn by news about a lucrative SPAC deal for its unit, declining cash reserves and slowing sales growth.
Stocktwits
<
...
1
>

Advertisement|Remove ads.